TipRanks
Estrella Immunopharma (ESLA)
NASDAQ:ESLA
US Market
ESLA
Estrella Immunopharma
RESEARCH TOOLSreports

Estrella Immunopharma (ESLA) Income Statement

48 Followers

Estrella Immunopharma Income Statement

Last quarter (Q2 2026), Estrella Immunopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Estrella Immunopharma's net income was $-2.31M. See Estrella Immunopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Jun 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 13.06M$ 8.85M$ 7.31M$ 11.11M$ 1.69M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -13.06M$ -8.85M$ -7.31M$ -11.11M$ -1.69M
Operating Income
$ -13.06M$ -8.85M$ -7.31M$ -11.11M$ -1.69M
Other Income/Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Pretax Income
$ -13.06M$ -8.85M$ -7.31M$ -11.11M$ -1.69M
Net Income
$ -13.06M$ -8.85M$ -7.31M$ -11.11M$ -1.69M
Per Share Metrics
Basic EPS
$ -0.35$ -0.24$ -0.21$ -0.32$ -0.05
Diluted EPS
$ -0.35$ -0.24$ -0.21$ -0.32$ -0.05
Weighted Average Shares Outstanding
 36.82M 36.68M 35.20M 35.20M 35.20M
Weighted Average Shares Outstanding (Diluted)
 36.82M 36.68M 35.20M 35.20M 35.20M
Currency in USD

Estrella Immunopharma Earnings and Revenue History